ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0282

Electronic Health Record-Based Calcium Pyrophosphate Deposition Disease Registry: A Feasibility Study

Nils Bürgisser1, Denis Mongin2, Samia Mehouachi2, Delphine Sophie Courvoisier3 and Kim Lauper4, 1Division of Rheumatology and internal medicine, Geneva University Hospital, Switzerland, Geneva, Switzerland, 2Division of Rheumatology, Geneva University Hospital, Switzerland, Geneva, Switzerland, 3Division of Rheumatology, Geneva University Hospitals, Geneva, Switzerland, 4Geneva University Hospitals, Geneva, Switzerland

Meeting: ACR Convergence 2024

Keywords: Crystal-induced arthritis, Epidemiology, pseudogout, quality of care, registry

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Despite its prevalence, calcium pyrophosphate deposition disease (CPPD) remains insufficiently studied. Leveraging electronic health record (EHR) data, a rich source of patient information, could facilitate the automatic enrollment of CPPD patients in registries without the need for manual recruitment1, enhancing research opportunities. However, registry reliability is often compromised due to the poor accuracy of diagnostic coding for CPPD. We describe the process and validation of creating a CPPD-registry out of EHR-data from a tertiary university hospital in Geneva, Switzerland integrating various sources of information to improve its accuracy.

Methods: We screened EHR-data from patients over 18 years old with any out- or inpatient visit at the Geneva University Hospital—Switzerland’s largest tertiary hospital—between January 1, 2013, and December 31, 2023. Screening criteria consisted of the presence of at least one of the following: ICD-10-GM codes for CPPD (M11) OR positive joint aspiration for CPP crystal OR CPPD-related terms (“pseudogout”, “chondrocalcinosis”) in the list of diagnosis OR documents OR imaging reports. A random sample of 200 medical charts were fully reviewed by a trained nurse or physician. The positive predictive value (PPV) to detect CPPD was established if any form of it was mentioned by any doctor in any part of the EHR.

Results: The four criteria identified 6709 patients presumably suffering from CPPD (figure 1A). Most patients were identified by screening medical reports (15.0%), followed by the list of diagnosis (5.1%). 3% of the patients had a positive joint aspiration for CPPD, without any documented diagnosis in the EHR. In the randomly selected 200 charts manually reviewed (table 1), the overall (any criterion) positive predictive value was 85.0% (CI 95% 79.3 to 89.6%). When taken alone (i.e. without any other criteria), both the ICD-10 codes and the list of diagnosis showed the best PPV (respectively 100% and 92.7%). The sole use of these two criteria would decrease the number of included patients to 1953. By using a combination of criteria (ICD-10 codes OR list of diagnosis OR ≥ 1 other criteria), the PPV reached 96.1% (CI 91.2% to 98.7%), leading to a registry of 5320 patients (Figure 1B).

Conclusion: The creation of a CPPD-register with automatic enrollment is feasible and valid. Incorporating various elements of the EHR, beyond only diagnostic codes, improves patient detection accuracy and increases registry numbers. Notably, a subset of patients exhibited positive joint aspirations without a corresponding documented diagnosis, indicating a documentation gap. The next step is to estimate the negative predictive value in a sample of patients without any criteria, yet with risk factors for CPPD, and develop a method to classify CPPD patients by clinical presentation. The final register will help assess pertinent clinical outcomes using clinical indicator to evaluate current quality of CPPD care and trajectories within the disease.

Supporting image 1

Figure 1A and 1B: Upset-plot of the criteria identifying patients suffering from calcium pyrophosphate deposition disease (CPPD). Figure 1A showed the resulting register if any criterion is fulfilled. Figure 1B showed the resulting register by mean of combining criteria (ICD_10-GM codes OR List of diagnosis OR ≥ 1 Other criteria), which lead to a higher positive predictive value of CPPD but lower number of patients in the registry.

Supporting image 2

Table 1: Results of the chart review looking for any CPPD-related terms (CPPD, pseudogout, chondrocalcinosis) among patients detected by the queries.


Disclosures: N. Bürgisser: None; D. Mongin: None; S. Mehouachi: None; D. Courvoisier: None; K. Lauper: None.

To cite this abstract in AMA style:

Bürgisser N, Mongin D, Mehouachi S, Courvoisier D, Lauper K. Electronic Health Record-Based Calcium Pyrophosphate Deposition Disease Registry: A Feasibility Study [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/electronic-health-record-based-calcium-pyrophosphate-deposition-disease-registry-a-feasibility-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/electronic-health-record-based-calcium-pyrophosphate-deposition-disease-registry-a-feasibility-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology